On the hand, the binding of cancer cells bearing DR3 to E-selectin induces endothelial cell retraction via p38 activation and adherens junction opening via disruption of the VE-cadherin-β-catenin complex subsequently to Erk and c-Src activation. This evidence concerns the gene TNFRSF25 and cancer.